ArticleCureus2025

Successful Re-administration and Extended Dosing of Brentuximab Vedotin Monotherapy for Relapsed Anaplastic Large Cell Lymphoma in a Vulnerable Patient.

Tomoki Minemura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.